199800 — ToolGen Income Statement
0.000.00%
HealthcareHighly SpeculativeSmall CapSucker Stock
- KR₩386bn
- KR₩340bn
- KR₩743m
Annual income statement for ToolGen, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2018 December 31st | R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,157 | 1,125 | 713 | 1,597 | 743 |
Cost of Revenue | |||||
Gross Profit | 771 | 682 | 362 | 1,086 | 558 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 9,488 | 17,260 | 15,679 | 22,337 | 20,129 |
Operating Profit | -8,332 | -16,135 | -14,966 | -20,740 | -19,386 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -7,705 | -15,781 | -14,882 | -20,692 | -18,177 |
Provision for Income Taxes | |||||
Net Income After Taxes | -8,057 | -15,781 | -14,882 | -20,692 | -18,177 |
Net Income Before Extraordinary Items | |||||
Net Income | -8,057 | -15,781 | -14,882 | -20,692 | -18,177 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -8,057 | -15,781 | -14,882 | -20,692 | -18,177 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1,269 | -2,435 | -2,269 | -3,014 | -2,314 |
Dividends per Share |